These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 700256)

  • 1. Immunoreactive glucagon responses to oral glucose, insulin infusion and deprivation, and somatostatin in pancreatectomized man.
    Werner PL; Palmer JP
    Diabetes; 1978 Oct; 27(10):1005-12. PubMed ID: 700256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon immunoreactivity and antidiabetic action of somatostatin in the totally duodeno-pancreatectomized and gastrectomized human.
    Bringer J; Mirouze J; Marchal G; Pham TC; Luyckx A; Lefebvre P; Orsetti A
    Diabetes; 1981 Oct; 30(10):851-6. PubMed ID: 6115786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of extrapancreatic immunoreactive glucagon to intraluminal nutrients in pancreatectomized dogs.
    Ohneda A; Kobayashi T; Nihei J
    Horm Metab Res; 1984 Jul; 16(7):344-8. PubMed ID: 6386643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extrapancreatic glucagon in control of glucose turnover in depancreatized dogs.
    Ross G; Lickley L; Vranic M
    Am J Physiol; 1978 Feb; 234(2):E213-19. PubMed ID: 623297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of extrapancreatic glucagon to arginine in dogs.
    Ohneda A; Kobayashi T; Nihei J; Umezu M; Sakai T; Sanoyama K
    Tohoku J Exp Med; 1979 Sep; 129(1):45-54. PubMed ID: 494257
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of somatostatin in regulating pancreatic splenic lobe hormone secretion following 99% pancreatectomy in adult chickens.
    Cieslak SR; Hazelwood RL
    Gen Comp Endocrinol; 1986 Aug; 63(2):284-94. PubMed ID: 2877920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A-Cell and gut glucagon in normal and depancreatized dogs. Inhibition by somatostatin and insulin.
    Matsuyama T; Wider MD; Tanaka R; Shima K; Tarui S; Nishikawa M; Foà PP
    Diabete Metab; 1979 Jun; 5(2):141-7. PubMed ID: 478084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucagon immunoreactivity and chromatographic profiles in pancreatectomized humans. Paradoxical response to oral glucose.
    Bajorunas DR; Fortner JG; Jaspan JB
    Diabetes; 1986 Aug; 35(8):886-93. PubMed ID: 3525286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cyclic somatostatin on insulin, C-peptide and immunoreactive glucagon response to oral glucose loading in obese patients.
    Papalia D; Trovato G; Maugeri D; Tribulato A; Lunetta M
    Int J Obes; 1982; 6(1):113-20. PubMed ID: 6121763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of total pancreatectomy on the secretion of gut glucagon in humans.
    Yasui K
    Jpn J Surg; 1983 Mar; 13(2):122-9. PubMed ID: 6350663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serum glucose response to glucagon suppression with somatostatin, insulin or antiglucagon serum in depancreatized rats.
    Dunbar JC; Walsh MF; Foà PP
    Diabetologia; 1978 Jan; 14(1):53-8. PubMed ID: 627333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon deficiency and hyperaminoacidemia after total pancreatectomy.
    Boden G; Master RW; Rezvani I; Palmer JP; Lobe TE; Owen OE
    J Clin Invest; 1980 Mar; 65(3):706-16. PubMed ID: 6986412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of graded glucagon infusions in man: inhibition of glucagon, insulin, and somatostatin response to arginine.
    Pontiroli AE; Perfetti MG; Andreotti AC; Fattor B; Monti LD; Pozza G
    Metabolism; 1993 Oct; 42(10):1242-8. PubMed ID: 8105365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intermittent endogenous hyperglucagonemia on glucose homeostasis in normal and diabetic man.
    Rizza R; Verdonk C; Miles J; Service FJ; Gerich J
    J Clin Invest; 1979 Jun; 63(6):1119-23. PubMed ID: 447838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response of extrapancreatic glucagon to glycemic changes.
    Ohneda A; Kobayashi T; Nihei J
    Endocrinol Jpn; 1980 Dec; 27 Suppl 1():121-6. PubMed ID: 7014202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of glucagon in the pathogenesis of the endogenous hyperglycemia of diabetes mellitus.
    Sakurai H; Dobbs RE; Unger RH
    Metabolism; 1975 Nov; 24(11):1287-97. PubMed ID: 1186499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible mechanisms and significance of the neonatal surge in glucagon secretion: studies in newborn lambs.
    Grajwer LA; Sperling MA; Sack J; Fisher DA
    Pediatr Res; 1977 Jul; 11(7):833-6. PubMed ID: 876705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of glucagon deficiency in the Houssay phenomenon of dogs.
    Nakabayashi H; Dobbs RE; Unger RH
    J Clin Invest; 1978 May; 61(5):1355-62. PubMed ID: 659597
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absence of islet alpha cell function in pancreatectomized patients.
    Tiengo A; Bessioud M; Valverde I; Tabbi-Anneni A; Delprato S; Alexandre J; Assan R
    Diabetologia; 1982 Jan; 22(1):25-32. PubMed ID: 6120875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of growth hormone on acute glucagon and insulin release.
    Sirek A; Vranic M; Sirek OV; Vigas M; Policova Z
    Am J Physiol; 1979 Aug; 237(2):E107-12. PubMed ID: 380363
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.